Last updated 11 days ago

Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participants With Previously Untreated High-risk Large B-cell Lymphoma

850 patients around the world
Available in Puerto Rico, Spain, Colombia, Chile, Brazil, Argentina, Mexico, United States
Celgene
850Patients around the world
This study is for people with
Non-Hodgkin Lymphoma
Large B-cell lymphoma
Requirements for the patient
To 80 Years
All Gender
Medical requirements
LinkedinInstagramFacebook
Terms and ConditionsPrivacy Policy